Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Seminars in Hematology|March 3, 2026
Emerging technologies for minimal residual disease detection in hematologic malignanciesDaniel J Groso, David G CoffeyCancer Medicine|July 16, 2016
Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancerAngel Qin, David G Coffey, Edus H Warren, et al.Frontiers in Immunology|May 19, 2022
Serial Analysis of the T-Cell Receptor β-Chain Repertoire in People Living With HIV Reveals Incomplete Recovery After Long-Term Antiretroviral TherapyAndrea M H Towlerton, Shashidhar Ravishankar, David G Coffey, et al.Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Individualized dynamic risk assessment for multiple myelomaCarl Murie, Serdar Turkarslan, Anoop Patel, et al.British Journal of Cancer|April 1, 2025
Individualized dynamic risk assessment and treatment selection for multiple myelomaCarl Murie, Serdar Turkarslan, Anoop P Patel, et al.Blood Cancer Discovery|January 4, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer TherapiesAndrew Kowalski, Jill Lykon, Benjamin Diamond, et al.Cancer Immunology, Immunotherapy : CII|November 6, 2019
Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinomaYuexin Xu, Alicia J Morales, Michael J Cargill, et al.Plos One|October 27, 2025
Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controlsDavid G Coffey, Yong Zhang, Elizabeth Hill, et al.Biomedicines|July 28, 2026
Navigating the Therapeutic Landscape of Multiple Myeloma: Immunotherapy, Microenvironment, and ResistanceSreejeta Mondal, Nathan Becker, Yang Huo, et al.JAMA|February 1, 2022
Diagnosis and Management of Multiple Myeloma: A ReviewAndrew J Cowan, Damian J Green, Mary Kwok, et al.Pageof 4